# Digital Integrated Healthcare Platform in Patients With Type 2 Diabetes

> **NCT04161170** · NA · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 294 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DEVICE:** Digital integrated healthcare platform

## Key facts

- **NCT ID:** NCT04161170
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-20
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 294 (ESTIMATED)
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04161170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04161170, "Digital Integrated Healthcare Platform in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04161170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
